A phase Ib GOELAMS study of the mTOR inhibitor RAD001 in association with chemotherapy for AML patients in first relapse. (Q45731131)
Jump to navigation
Jump to search
scientific article published on 16 January 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase Ib GOELAMS study of the mTOR inhibitor RAD001 in association with chemotherapy for AML patients in first relapse. |
scientific article published on 16 January 2013 |
Statements
A phase Ib GOELAMS study of the mTOR inhibitor RAD001 in association with chemotherapy for AML patients in first relapse (English)
F Saint Marcoux
C Recher
P Chevallier
J-Y Cahn
T Leguay
P Bories
F Witz
T Lamy
P Mayeux
C Lacombe
C Demur
A Merlat
R Delepine
N Vey
F Dreyfus
M C Béné
GOELAMS (Groupe Ouest Est d’Etude des Leucémies aiguës et Autres Maladies du Sang)
16 January 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference